atherosclerosis
atherosclerosis
Explore linked clinical trials. Standard reference: MONDO:0005311528 results · Page 1 of 22
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management | Arterial Occlusive Diseases, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, hypertensive disorder, metabolic disease, vascular disorder | Recruiting | Not stated | 2026-10-09 | NCT07208331 | |
| Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure | Arterial Occlusive Diseases, Disease Attributes, Genetic Risk Score, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, disease susceptibility, hypertensive disorder, inherited disease susceptibility, vascular disorder | Recruiting | Not applicable | 2026-10-09 | NCT06962488 | |
| Tissue Validation of Mammographic Breast Arterial Calcification in Mastectomy Specimens (SIDEMARA) | Arterial Occlusive Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, Vascular Calcification, arteriosclerosis disorder, atherosclerosis, breast cancer, breast disorder, breast neoplasm, calcinosis, calcium metabolic disease, cardiovascular disorder, metabolic disease, neoplasm, skin disorder, vascular disorder | Not yet recruiting | Not stated | 2026-10-08 | NCT07865884 | |
| A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event | Arterial Occlusive Diseases, Body Weight, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, kidney disorder, kidney failure, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, urinary system disorder, vascular disorder | Recruiting | Phase 2 | 2026-10-08 | NCT07783802 | |
| A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07613294 | |
| Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07223593 | |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity | Arterial Occlusive Diseases, Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07037433 | |
| The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) | Arterial Occlusive Diseases, Chronic Disease, Death, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, arteriosclerosis disorder, atherosclerosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, chronic renal failure syndrome, coronary artery disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, kidney disorder, kidney failure, metabolic disease, myocardial ischemia, nervous system disorder, peripheral arterial disease, peripheral vascular disease, type 2 diabetes mellitus, urinary system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-10-08 | NCT06383390 | |
| A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-10-08 | NCT06292013 | |
| Guideline Oriented Approach To Lipid Lowering In Asia-Pacific | Arterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, acute coronary syndrome, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, heart disorder, hyperlipidemia, metabolic disease, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-10-08 | NCT05325034 | |
| Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS | Arterial Occlusive Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm, vascular disorder | Active, not recruiting | Not stated | 2026-10-08 | NCT05180942 | |
| A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND) | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Active, not recruiting | Not applicable | 2026-10-08 | NCT03477604 | |
| DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial Disease | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Not yet recruiting | Not applicable | 2026-10-07 | NCT07764016 | |
| Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-10-07 | NCT06813911 | |
| New Heart Imaging Techniques to Evaluate Possible Heart Disease | Arterial Occlusive Diseases, Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Recruiting | Not applicable | 2026-10-07 | NCT01399385 | |
| Hemodynamic Characteristics of Peripheral Arterial Disease Using Computational Fluid Dynamics | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Not yet recruiting | Not stated | 2026-10-06 | NCT07860138 | |
| How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Recruiting | Not applicable | 2026-10-06 | NCT07121010 | |
| Laser Atherectomy and Sirolimus-coated Balloon Angioplasty for CLTI | Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Active, not recruiting | Not stated | 2026-10-05 | NCT07858539 | |
| Improving Mobility After Revascularization in Peripheral Artery Disease | Arterial Occlusive Diseases, Mobility Limitation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Phase 3 | 2026-10-05 | NCT06686121 | |
| Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression | Aneurysm, Arterial Occlusive Diseases, abdominal aortic aneurysm, aortic aneurysm, aortic disorder, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not stated | 2026-10-05 | NCT06206369 | |
| Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk | Arterial Occlusive Diseases, Infarction, Inflammation, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, peripheral arterial disease, peripheral vascular disease, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-10-05 | NCT04774159 | |
| Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging | Angina Pectoris, Arterial Occlusive Diseases, Cardiovascular Abnormalities, Chest Pain, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiomyopathy, cardiovascular disorder, congenital heart disease, coronary artery disorder, heart disorder, heart failure, heart valve disorder, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2026-10-05 | NCT03581318 | |
| PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis | Arterial Occlusive Diseases, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, hyperlipidemia, metabolic disease, vascular disorder | Not yet recruiting | Not stated | 2026-10-02 | NCT07856264 | |
| Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery Disease | Arterial Occlusive Diseases, Genital Diseases, Male Urogenital Diseases, Sexual Dysfunctions, Psychological, Urogenital Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, coronary artery disorder, erectile dysfunction, heart disorder, male reproductive system disorder, myocardial ischemia, physiological sexual disorder, psychiatric disorder, vascular disorder | Recruiting | Not applicable | 2026-10-02 | NCT07856199 | |
| Passive Calf Stretching Therapy in Peripheral Artery Disease | Arterial Occlusive Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2026-10-02 | NCT06041880 |